查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1416338

一氧化氮吸入市場報告：2030 年趨勢、預測與競爭分析

Inhaled Nitric Oxide Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

吸入一氧化氮的趨勢和預測

預計到 2030 年，全球吸入一氧化氮市場將達到 11 億美元，2024 年至 2030 年複合年成長率為 5.1%。該市場的主要促進因素是呼吸系統疾病和其他相關疾病的日益流行，以及持續的研發活動。全球吸入一氧化氮市場前景廣闊，新生兒呼吸治療、氣喘和慢性阻塞性肺病、急性呼吸窘迫症候群、瘧疾治療和結核病治療市場充滿機會。

吸入一氧化氮市場洞察

Lucintel 預測，緊湊型可攜式輸送系統的引入將在預測期內實現更高的成長。這有利於在各種醫療保健應用中進行一氧化氮療法。

在這個市場中，由於菸草消費量的增加，導致氣喘和慢性阻塞性肺病的症狀，預計氣喘和慢性阻塞性肺病的成長最快。

由於慢性阻塞性肺病和氣喘等疾病發病率急劇上升、人口老化加劇以及主要保險公司在該地區的存在，預計北美地區在預測期內將出現最高的成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球吸入一氧化氮市場預計將達到 11 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球吸入一氧化氮市場預計將以5.1%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 此市場的主要促進因素是呼吸道疾病和其他相關疾病的日益流行，以及持續的研發活動。

Q4.市場的主要細分市場是：

A4. 吸入一氧化氮市場的未來前景廣闊，在新生兒呼吸治療、氣喘和慢性阻塞性肺病、急性呼吸窘迫症候群、瘧疾治療和結核病治療市場上都有機會。

Q5.市場的主要企業是：

A5.主要的吸入一氧化氮公司如下。

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Q6.未來最大的細分市場是什麼？

A6.Lucintel預測，由於緊湊型和可攜式輸送系統的引入，輸送系統在預測期內將出現更高的成長。這有利於在各種醫療保健應用中進行一氧化氮療法。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於慢性阻塞性肺病和氣喘等疾病的發生率急劇上升、人口老化以及主要保險公司在該地區的存在，預計北美地區將在預測期內出現最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球吸入一氧化氮市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球吸入一氧化氮市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球吸入一氧化氮市場
    • 氣體
    • 輸送系統
  • 全球吸入一氧化氮市場（按應用）
    • 新生兒呼吸治療
    • 氣喘及慢性阻塞性肺病
    • 急性呼吸頻率綜合症
    • 瘧疾治療
    • 結核病治療
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球吸入一氧化氮市場區域分佈
  • 北美吸入一氧化氮市場
  • 歐洲吸入一氧化氮市場
  • 亞太地區吸入一氧化氮市場
  • 其他區域吸入一氧化氮市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球吸入一氧化氮市場成長機會
    • 全球吸入一氧化氮市場成長機會（按應用）
    • 按地區分類的全球吸入一氧化氮市場成長機會
  • 全球吸入一氧化氮市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球吸入一氧化氮市場產能擴張
    • 全球吸入一氧化氮市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure
簡介目錄

Inhaled Nitric Oxide Trends and Forecast

The future of the global inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets. The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

A more than 150-page report is developed to help in your business decisions.

Inhaled Nitric Oxide by Segment

The study includes a forecast for the global inhaled nitric oxide by product type, application, and region.

Inhaled Nitric Oxide Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Gas
  • Delivery Systems

Inhaled Nitric Oxide Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Neonatal Respiratory Treatment
  • Asthma and COPD
  • Acute Respiratory Distress Syndrome
  • Malaria Treatment
  • Tuberculosis Treatment
  • Others

Inhaled Nitric Oxide Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Inhaled Nitric Oxide Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inhaled nitric oxide companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inhaled nitric oxide companies profiled in this report include-

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Inhaled Nitric Oxide Market Insights

Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Within this market, asthma and COPD is expected to witness the highest growth due growing consumption of cigarettes, which contributes to asthma and COPD symptoms.

North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Features of the Global Inhaled Nitric Oxide Market

Market Size Estimates: Inhaled nitric oxide market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inhaled nitric oxide market size by product type, application, and region in terms of value ($B).

Regional Analysis: Inhaled nitric oxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the inhaled nitric oxide market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inhaled nitric oxide market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the inhaled nitric oxide market size?

Answer: The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030.

Q2. What is the growth forecast for inhaled nitric oxide market?

Answer: The global inhaled nitric oxide market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the inhaled nitric oxide market?

Answer: The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

Q4. What are the major segments for inhaled nitric oxide market?

Answer: The future of the inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets.

Q5. Who are the key inhaled nitric oxide market companies?

Answer: Some of the key inhaled nitric oxide companies are as follows:

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Q6. Which inhaled nitric oxide market segment will be the largest in future?

Answer: Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Q7. In inhaled nitric oxide market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the inhaled nitric oxide market by product type (gas and delivery systems), application (neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, tuberculosis treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inhaled Nitric Oxide Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Inhaled Nitric Oxide Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Inhaled Nitric Oxide Market by Product Type
    • 3.3.1: Gas
    • 3.3.2: Delivery Systems
  • 3.4: Global Inhaled Nitric Oxide Market by Application
    • 3.4.1: Neonatal Respiratory Treatment
    • 3.4.2: Asthma and COPD
    • 3.4.3: Acute Respiratory Distress Syndrome
    • 3.4.4: Malaria Treatment
    • 3.4.5: Tuberculosis Treatment
    • 3.4.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Inhaled Nitric Oxide Market by Region
  • 4.2: North American Inhaled Nitric Oxide Market
    • 4.2.2: North American Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.3: European Inhaled Nitric Oxide Market
    • 4.3.1: European Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.3.2: European Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.4: APAC Inhaled Nitric Oxide Market
    • 4.4.1: APAC Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.4.2: APAC Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.5: ROW Inhaled Nitric Oxide Market
    • 4.5.1: ROW Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.5.2: ROW Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Application
    • 6.1.3: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Region
  • 6.2: Emerging Trends in the Global Inhaled Nitric Oxide Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Inhaled Nitric Oxide Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inhaled Nitric Oxide Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Air Liquide Healthcare
  • 7.2: BOC Healthcare
  • 7.3: Matheson Tri-Gas
  • 7.4: Merck
  • 7.5: Mallinckrodt Pharmaceuticals
  • 7.6: Nu-Med Plus
  • 7.7: Perma Pure